XML 88 R74.htm IDEA: XBRL DOCUMENT v3.25.4
Shareholders’ Equity (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Sep. 26, 2024
Jul. 31, 2025
Jan. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]            
Shares unsettled (in shares)       8,840,000    
Common stock            
Subsidiary, Sale of Stock [Line Items]            
Number of shares sold (in shares)       3,185,262 5,983,711 7,662,341
Public Offering            
Subsidiary, Sale of Stock [Line Items]            
Maximum Sales Authorization (in shares)   12,420,000 11,040,000      
Shares unsettled (in shares)   4,264,947 8,840,000      
Value of Gross Proceeds of Unsettled Forward Equity   $ 75,490 $ 159,120      
Public Offering | Common stock            
Subsidiary, Sale of Stock [Line Items]            
Number of shares sold (in shares) 2,200,000 8,155,053 2,200,000